Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
EV/Core EBITDA

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 19.4831.1331.3232.6710.70

What is the latest EV/Core EBITDA ratio of MEDICAMEN BIOTECH ?

The latest EV/Core EBITDA ratio of MEDICAMEN BIOTECH is 19.48 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202419.48
Mar202331.13
Mar202231.32
Mar202132.67
Mar202010.70

How is EV/Core EBITDA of MEDICAMEN BIOTECH Trending?

Years EV/Core EBITDA % Change
Mar2024 19.48
-37.42
Mar2023 31.13
-0.61
Mar2022 31.32
-4.13
Mar2021 32.67
205.33
Mar2020 10.7 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare EV/Core EBITDA ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹592.5 Cr -10.8% -1.9% -2.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,363.0 Cr -2.8% -3.6% 10.8% Stock Analytics
DIVIS LABORATORIES ₹158,396.0 Cr -2.5% 1.5% 59.1% Stock Analytics
CIPLA ₹117,088.0 Cr -1.5% 0.2% 1.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,458.0 Cr -1.6% -9.2% -4.3% Stock Analytics
ZYDUS LIFESCIENCES ₹94,002.4 Cr -7.4% -5.1% 9.9% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-10.8%

-1.9%

-2.8%

SENSEX

-2.7%

-0.4%

6.4%


You may also like the below Video Courses